FAS

FAS
Name	Fetal alcohol syndrome
Synonyms	Fetal alcohol spectrum disorders
Specialty	American Academy of Pediatrics American College of Obstetricians and Gynecologists
Symptoms	Facial dysmorphology, growth restriction, neurodevelopmental impairment
Onset	Prenatal
Causes	Prenatal alcohol exposure
Risks	Binge drinking, chronic alcohol use, malnutrition, concurrent tobacco or opioid exposure
Diagnosis	Clinical criteria, neurodevelopmental assessment, maternal history
Differential	Down syndrome, Williams syndrome, Angelman syndrome
Treatment	Multidisciplinary interventions, behavioral therapies, pharmacotherapy for comorbidities
Prognosis	Variable; lifelong disabilities possible

FAS

Fetal alcohol syndrome is the most well-characterized disorder within the fetal alcohol spectrum disorders group, defined by a pattern of craniofacial anomalies, growth deficits, and central nervous system dysfunction attributable to prenatal alcohol exposure. Clinicians, researchers, and public health bodies including World Health Organization, Centers for Disease Control and Prevention, American Psychiatric Association, and National Institutes of Health use standardized criteria to identify affected individuals and guide prevention, diagnosis, and management. Recognition involves multidisciplinary teams from pediatrics, neurodevelopmental pediatrics, genetics, and psychiatry, and informs interventions spanning early childhood through adult services coordinated by agencies such as UNICEF and national health ministries.

Terminology and Abbreviations

Common terms include fetal alcohol spectrum disorders (FASD), partial fetal alcohol syndrome, alcohol-related neurodevelopmental disorder, and alcohol-related birth defects; professional guidelines are published by American Academy of Pediatrics and National Institute on Alcohol Abuse and Alcoholism. Abbreviations encountered in literature and policy documents include FAS, FASD, PAE (prenatal alcohol exposure), and CNS (central nervous system) impairment; these appear in consensus statements from organizations such as World Health Organization, Royal College of Physicians, and Canadian Paediatric Society. Diagnostic nomenclature is referenced in classification systems like the Diagnostic and Statistical Manual of Mental Disorders and the International Classification of Diseases.

Causes and Pathophysiology

Etiology is maternal alcohol consumption during pregnancy, with risk modified by timing, dose, pattern (including binge episodes), maternal genetics, placental function, maternal nutrition, and co-exposures such as tobacco or illicit drugs; research funding and reports by National Institutes of Health, Medical Research Council (United Kingdom), and European Commission elaborate these factors. Teratogenic mechanisms involve ethanol and metabolites causing oxidative stress, apoptosis, disruption of neural crest cell migration, altered neurogenesis, and epigenetic modifications, themes explored in studies from Harvard Medical School, University of Cambridge, and Johns Hopkins University. Animal models used to elucidate mechanisms include work from laboratories at University of California, San Diego, McGill University, and Max Planck Institute, which demonstrate dose-dependent craniofacial and brain structural changes mirroring clinical findings.

Clinical Features

Cardinal features encompass distinctive facial morphology (smooth philtrum, thin upper lip, short palpebral fissures), prenatal and postnatal growth restriction, and central nervous system dysfunction manifesting as global developmental delay, intellectual disability, attention deficits, executive dysfunction, and social communication impairments; clinical practice guidelines by American Academy of Pediatrics, Royal College of Paediatrics and Child Health, and British Medical Journal summarize these domains. Co-occurring conditions include sensory problems, seizure disorders, cardiac defects (e.g., interventricular septal defects noted in case series from Mayo Clinic), and psychiatric comorbidities such as mood and substance use disorders referenced in reviews from Lancet Psychiatry and Journal of the American Academy of Child and Adolescent Psychiatry. Facial dysmorphology and neurobehavioral profiles inform diagnostic evaluations performed by teams at centers like Children's Hospital of Philadelphia and SickKids Hospital.

Diagnosis

Diagnosis relies on standardized criteria combining facial features, growth metrics, and evidence of CNS impairment with confirmed or unknown prenatal alcohol exposure; frameworks are provided by Centers for Disease Control and Prevention, Institute of Medicine (US), and multidisciplinary consensus panels convened by World Health Organization. Assessment tools include neuropsychological batteries from institutions such as Weill Cornell Medicine and developmental scales employed in clinics at Boston Children's Hospital and Seattle Children's Hospital. Genetic testing and imaging (MRI) from services at Mayo Clinic, Cleveland Clinic, and university centers help exclude syndromes like Noonan syndrome or Smith-Lemli-Opitz syndrome, while maternal history is elicited using validated screening instruments promoted by Substance Abuse and Mental Health Services Administration.

Management and Treatment

Management is multidisciplinary and individualized, integrating early developmental interventions, special education, behavioral therapies, speech and occupational therapy, and pharmacotherapy for comorbid attention or mood disorders; models of care are described by American Academy of Pediatrics, National Health Service (UK), and programs at Kennedy Krieger Institute. Social supports and case management from agencies such as Department of Health and Human Services (US), Centers for Medicare & Medicaid Services, and nonprofit organizations like March of Dimes facilitate access to services. Research into neuroprotective agents, nutritional interventions (e.g., choline supplementation), and targeted cognitive training is ongoing at centers including University of North Carolina, University of Alberta, and Stanford University.

Prognosis and Long-term Outcomes

Outcomes vary widely: some individuals achieve adaptive functioning with supports while others experience persistent intellectual disability, mental health disorders, and socioeconomic challenges; longitudinal cohorts from University of Washington, Duke University, and University of Southern California document elevated risks for school failure, unemployment, incarceration, and comorbid substance use. Lifespan considerations emphasize transition planning from pediatric to adult services guided by recommendations from American Academy of Family Physicians and disability services frameworks administered by national welfare agencies.

Epidemiology and Prevention

Prevalence estimates differ by region and methodology; surveillance reports by Centers for Disease Control and Prevention, Public Health England, Canadian Paediatric Surveillance Program, and World Health Organization indicate varying rates influenced by alcohol consumption patterns, prenatal care access, and case-ascertainment methods. Prevention strategies include public health campaigns, brief interventions in prenatal care settings advocated by World Health Organization, screening and brief intervention protocols promoted by U.S. Preventive Services Task Force, and policy measures such as warning labels and alcohol taxation studied by World Bank and Organisation for Economic Co-operation and Development. Primary prevention prioritizes abstinence during pregnancy as recommended by clinical bodies including American College of Obstetricians and Gynecologists and Royal College of Obstetricians and Gynaecologists.

Category:Developmental disorders